GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » St Jude Medical Inc (NYSE:STJ) » Definitions » Cyclically Adjusted PB Ratio

St Jude Medical (St Jude Medical) Cyclically Adjusted PB Ratio : (As of May. 05, 2024)


View and export this data going back to 1977. Start your Free Trial

What is St Jude Medical Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


St Jude Medical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for St Jude Medical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

St Jude Medical Cyclically Adjusted PB Ratio Chart

St Jude Medical Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

St Jude Medical Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of St Jude Medical's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, St Jude Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


St Jude Medical's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, St Jude Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where St Jude Medical's Cyclically Adjusted PB Ratio falls into.



St Jude Medical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

St Jude Medical's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2016 is calculated as:

For example, St Jude Medical's adjusted Book Value per Share data for the three months ended in Sep. 2016 was:

Adj_Book=Book Value per Share/CPI of Sep. 2016 (Change)*Current CPI (Sep. 2016)
=15.707/101.8610*101.8610
=15.707

Current CPI (Sep. 2016) = 101.8610.

St Jude Medical Quarterly Data

Book Value per Share CPI Adj_Book
200612 8.389 85.142 10.036
200703 7.470 86.640 8.782
200706 7.204 87.906 8.348
200709 8.070 87.964 9.345
200712 8.540 88.616 9.816
200803 9.357 90.090 10.580
200806 9.358 92.320 10.325
200809 10.071 92.307 11.113
200812 9.348 88.697 10.735
200903 9.912 89.744 11.250
200906 10.869 91.003 12.166
200909 10.659 91.120 11.916
200912 10.241 91.111 11.449
201003 10.959 91.821 12.157
201006 11.655 91.962 12.910
201009 12.746 92.162 14.087
201012 13.287 92.474 14.636
201103 13.869 94.283 14.984
201106 14.688 95.235 15.710
201109 13.910 95.727 14.801
201112 14.001 95.213 14.979
201203 14.076 96.783 14.815
201206 14.426 96.819 15.177
201209 15.043 97.633 15.694
201212 13.848 96.871 14.561
201303 13.219 98.209 13.711
201306 13.485 98.518 13.943
201309 14.746 98.790 15.204
201312 14.634 98.326 15.160
201403 14.310 99.695 14.621
201406 13.983 100.560 14.164
201409 14.341 100.428 14.546
201412 14.648 99.070 15.061
201503 13.715 99.621 14.023
201506 13.645 100.684 13.805
201509 14.151 100.392 14.358
201512 14.260 99.792 14.556
201603 14.440 100.470 14.640
201606 15.042 101.688 15.068
201609 15.707 101.861 15.707

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


St Jude Medical  (NYSE:STJ) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


St Jude Medical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of St Jude Medical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


St Jude Medical (St Jude Medical) Business Description

Traded in Other Exchanges
N/A
Address
St Jude Medical Inc was incorporated in Minnesota in 1976. It develops, manufactures and distributes cardiovascular medical devices for the cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The Company's two segments are the Implantable Electronic Systems Division and the Cardiovascular and Ablation Technologies Division. The Company's principal products in each business unit are as follows: Implantable Electronic Systems Division (IESD) - tachycardia implantable cardioverter defibrillator systems (ICDs), bradycardia pacemaker systems (pacemakers) and neurostimulation products (spinal cord and deep brain stimulation devices); and Cardiovascular and Ablation Technologies Division (CATD) - vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories), structural heart products (heart valve replacement and repair products and structural heart defect devices) and atrial fibrillation (AF) products (electrophysiology (EP) introducers and catheters, cardiac mapping, navigation and recording systems and ablation systems). Implantable Electronic Systems Division (IESD): IESD is focused on the cardiac rhythm management and neuromodulation therapy areas. Cardiac rhythm management devices include ICDs that provide life-saving therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy (CRT) devices to save and improve the lives of patients suffering from heart failure (HF); pacemakers to help patients whose hearts beat too slowly or who suffer from other debilitating cardiac arrhythmias; leads (wires that connect devices to the heart) to carry electrical impulses to the heart and provide information from the heart to the device; and programmers and remote monitoring equipment which are used by physicians and healthcare professionals to program is cardiac rhythm management devices and analyze device data to improve patient management. Neuromodulation product offerings provide neurostimulation treatment in which an implantable device delivers electrical current directly to targeted nerve sites. The Company's commercialized neurostimulation therapies include spinal cord stimulation (SCS) for the treatment of chronic pain, deep brain stimulation (DBS) for treating the symptoms of Parkinson's disease and peripheral nerve stimulation (PNS) for the treatment of chronic migraine headache. A neurostimulation system typically consists of four components: a pulse generator that produces the electrical current and is implanted under the patient's skin; implanted leads that carry the electrical impulses to the targeted nerve sites; an external patient remote control that enables the patient to control his or her therapy within prescribed ranges; and an external clinician pro
Executives
Jeff Fecho officer: VP, Global Quality ONE ST. JUDE MEDICAL DRIVE ST. PAUL MN 55117
Philip Ebeling officer: VP, Chief Technology Officer INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY MN 55416
Donald Zurbay officer: VP Finance and CFO C/O ST. JUDE MEDICAL, INC., ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117
Michael A Rocca director C/O LIGAND PHARMACEUTICALS INCORPORATED, 10275 SCIENCE CENTER DRIVE, SAN DIEGO CA 92121
Barbara B Hill director
Wendy L Yarno director
Stuart Essig director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
John C Heinmiller officer: Executive Vice President ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117
John W Brown director STRYKER CORP, 2725 FAIRFIELD ROAD, KALAMAZOO MI 49002
David C Dvorak director C/O ZIMMER INC, PO BOX 708, WARSAW IN 46580
Michael T Rousseau director, officer: Director, President and CEO ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117
Eric S Fain officer: Group President ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN MN
Daniel J Starks director ONE ST JUDE MEDICAL DRIVE, ST PAUL MN 55117
Joel Becker officer: President, Americas ONE ST. JUDE MEDICAL DRIVE, ST. PAUL MN 55418
Rohan Hoare officer: President - NMD 100 CYBERONICS BLVD, HOUSTON TX 77058

St Jude Medical (St Jude Medical) Headlines

From GuruFocus

Mairs & Power Growth Fund 3rd Quarter Results

By Holly LaFon Holly LaFon 10-31-2016

Richard Perry Exits AIG, Time Warner

By Tiziano Frateschi Tiziano Frateschi 11-14-2016

Sarah Ketterer Returns 24 Pct in 2012, Her Top Q4 Buys

By Holly LaFon Holly LaFon 02-25-2013

Richard Perry Buys St. Jude

By Sydnee Gatewood Sydnee Gatewood 08-15-2016